MSL
CORT icon

Mackay Shields LLC’s Corcept Therapeutics CORT Stock Holding History

Mackay Shields LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-99,100
Closed -$2.36M – 837
2021
Q1 		$2.36M Sell
99,100
-65,500
-40% -$1.75M 0.02% 700
2020
Q4 		$4.31M Sell
164,600
-23,200
-12% -$489K 0.03% 535
2020
Q3 		$3.27M Sell
187,800
-23,500
-11% -$375K 0.02% 574
2020
Q2 		$3.55M Sell
211,300
-25,600
-11% -$360K 0.03% 515
2020
Q1 		$2.82M Sell
236,900
-16,300
-6% -$202K 0.03% 526
2019
Q4 		$3.06M Buy
+253,200
New +$3.52M 0.02% 701
2018
Q2 		– Sell
-49,300
Closed -$811K – 1219
2018
Q1 		$811K Buy
+49,300
New +$914K 0.01% 1026

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return